|
Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia
|
5
|
693
|
June 9, 2022
|
|
Newron Presents Encouraging Detailed Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia
|
10
|
1032
|
March 26, 2017
|
|
Newron announces encouraging preliminary results of its Phase IIa study with Evenamide in patients with schizophrenia
|
14
|
1458
|
January 4, 2017
|
|
Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA
|
3
|
364
|
January 9, 2020
|
|
Newron's Schizophrenia Candidate Scores Mid-Stage Win, Moves to Phase III
|
2
|
234
|
October 11, 2023
|